The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Comprehensive functional kinase profiling to classify clear cell (cc)-renal cell carcinoma (RCC).
Amitkumar N. Mehta
Consultant or Advisory Role - IMS Health
Honoraria - IMS Health
Christopher Douglas Willey
No relevant relationships to disclose
Joshua Anderson
No relevant relationships to disclose
Karim Youssry Welaya
No relevant relationships to disclose
Dongquan Chen
No relevant relationships to disclose
Pooja Ghatalia
No relevant relationships to disclose
Ankit Madan
No relevant relationships to disclose
Sunil Sudarshan
No relevant relationships to disclose
Gurudatta Naik
No relevant relationships to disclose
William E. Grizzle
No relevant relationships to disclose
Toni K. Choueiri
No relevant relationships to disclose
Guru Sonpavde
Consultant or Advisory Role - Amgen; Astellas Pharma; Dendreon; GlaxoSmithKline; Janssen Pharmaceutical ; Novartis; Pfizer; Sanofi
Research Funding - Bellicum Pharmaceuticals; Bristol-Myers Squibb; Novartis; Pfizer